Call for Submissions: 2027 AACR June L. Biedler Prize for Cancer Journalism
Awardees will receive $5,000 unrestricted cash prize PHILADELPHIA – The American Association for Cancer Research (AACR) is inviting journalists...
Search/Filter
Loading...
AACR Applauds Bipartisan Senate Provision to Delay Harmful OMB Grantmaking Rule
PHILADELPHIA – The American Association for Cancer Research (AACR) commends Senate appropriators for including a bipartisan provision in its...
AACR Center for Cancer Clinical Trials Announces First Patient Enrolled in Phase II Clinical Trial for Locally Advanced Gastroesophageal Cancer
First-ever AACR-sponsored clinical trial will test whether biomarker-directed treatment approaches can help patients skip surgery and preserve their organs...
A Vaccine to Prevent Pancreatic Cancer in High-risk Individuals Was Safe and Elicited Durable Immune Responses
A Vaccine to Prevent Pancreatic Cancer in High-risk Individuals Was Safe and Elicited Durable Immune Responses PHILADELPHIA – A...
Men May Be More Likely Than Women to Receive Later-stage Diagnoses for Many Cancer Types in the United States
PHILADELPHIA – Between 2015 and 2022, men were more likely than women to be diagnosed with regional and/or distant...
AACR Statement and Call to Action Concerning OMB Proposal to Rewrite the Rules for Scientists and Physicians Who Are Improving Public Health and Saving Lives
The comment period for the OMB’s proposed changes closes at 11:59 p.m. Monday, July 13. PHILADELPHIA – The American...
AACR Names Matthew Vander Heiden, MD, PhD, FAACR, as Editor-in-Chief of the Journal Cancer Discovery
PHILADELPHIA – The American Association for Cancer Research (AACR) today announced the appointment of Matthew Vander Heiden, MD, PhD, Fellow...
AACR Releases Cancer Disparities Progress Report 2026
Report features latest statistics, including promising signs of progress, and 10 compelling personal stories PHILADELPHIA – The American Association...
Adding a Lower Cutoff Value for CA19-9 May Identify Additional High-risk Cases of Pancreatic Cancer
CA19-9 is a biomarker whose levels often correlate with pancreatic cancer stage and prognosis PHILADELPHIA – A dual-threshold model...
Emerging Frontiers in Oncology to Support AACR and Early-Career Investigators Through Annual Oncology Summit
PHILADELPHIA – The American Association for Cancer Research (AACR) today thanked Emerging Frontiers in Oncology (EFO) for its support...